Literature DB >> 29753962

The management of adolescents and young adults with cancer.

Nicola Hughes1, Dan Stark2.   

Abstract

Adolescents and Young Adults (AYA) with cancer are young people developing serious illness when at the interface between the responsibilities of paediatric and adult cancer services. Personally, they are in a period of transition both biologically and in major social roles (Sawyer et al., 2018) [1]. For these and other reasons they present a unique set of clinical challenges in their management. Over the last 20 years the requirement for specific services to address their needs has been identified and this has become a growing field of research. Despite this survival rates still lag behind those of children and older adults with cancer (Gatta et al., 2009) [2]. Why do AYA patients have worse outcomes? The observation is that the reason is multifactorial with path to diagnosis, unique cancer biology, uncertainty of treatment protocol, compliance issues and poor recruitment to clinical trials all playing a part. In this review we will discuss the unique challenges faced by healthcare professionals when managing AYA patients who are commonly and accurately described as being in an 'interface' position.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adolescent; Biology; Cancer; Clinical trials; Epidemiology; Late effects; Palliative care; Psychosocial; Survival; Survivorship; Training; Young adult

Mesh:

Year:  2018        PMID: 29753962     DOI: 10.1016/j.ctrv.2018.05.001

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


  10 in total

1.  Provider perceptions' of a patient navigator for adolescents and young adults with cancer.

Authors:  Kayla N LaRosa; Marilyn Stern; Courtney Lynn; Janella Hudson; Damon R Reed; Kristine A Donovan; Gwendolyn P Quinn
Journal:  Support Care Cancer       Date:  2019-02-18       Impact factor: 3.603

Review 2.  Understanding, measuring, and addressing the financial impact of cancer on adolescents and young adults.

Authors:  John M Salsman; Kristin Bingen; Ronald D Barr; David R Freyer
Journal:  Pediatr Blood Cancer       Date:  2019-02-12       Impact factor: 3.167

3.  Financial burdens during the COVID-19 pandemic are related to disrupted healthcare utilization among survivors of adolescent and young adult cancers.

Authors:  Judy Y Ou; Austin R Waters; Heydon K Kaddas; Echo L Warner; Perla L Vaca Lopez; Karely Mann; John S Anderson; Nicole Ray; Tomoko Tsukamoto; David Gill; Lauri Linder; Douglas Fair; Anne C Kirchhoff
Journal:  J Cancer Surviv       Date:  2022-05-17       Impact factor: 4.062

4.  Caught in the In-Between: Challenges in Treating Adolescents and Young Adults With Cancer.

Authors:  Sanyukta K Janardan; Daniel S Wechsler
Journal:  JCO Oncol Pract       Date:  2021-04-29

5.  Genomic Features and Clinical Characteristics of Adolescents and Young Adults With Cholangiocarcinoma.

Authors:  Hao Feng; Huan Tong; Jiayan Yan; Min He; Wei Chen; Jian Wang
Journal:  Front Oncol       Date:  2020-01-14       Impact factor: 6.244

6.  Transcriptomics analysis for the identification of potential age-related genes and cells associated with three major urogenital cancers.

Authors:  Jinlong Cao; Jianpeng Li; Xin Yang; Pan Li; Zhiqiang Yao; Dali Han; Lijun Ying; Lijie Wang; Junqiang Tian
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

7.  Analysis of metastasis and survival between extrahepatic and intrahepatic cholangiocarcinoma: A large population-based study.

Authors:  Peng Liao; Li Cao; Hang Chen; Shui-Zi Pang
Journal:  Medicine (Baltimore)       Date:  2021-04-23       Impact factor: 1.817

8.  Covid-19 and beyond: Broadening horizons about social media use in oncology. A survey study with healthcare professionals caring for youth with cancer.

Authors:  Michael Rost; Vittoria Espeli; Marc Ansari; Nicolas von der Weid; Bernice S Elger; Eva De Clercq
Journal:  Health Policy Technol       Date:  2022-03-04       Impact factor: 5.211

Review 9.  Systematic target actionability reviews of preclinical proof-of-concept papers to match targeted drugs to paediatric cancers.

Authors:  Nil A Schubert; Caitlin D Lowery; Guillaume Bergthold; Jan Koster; Thomas F Eleveld; Ana Rodríguez; David T W Jones; Gilles Vassal; Louis F Stancato; Stefan M Pfister; Hubert N Caron; Jan J Molenaar
Journal:  Eur J Cancer       Date:  2020-03-27       Impact factor: 9.162

10.  Survival after cancer in children, adolescents and young adults in the Nordic countries from 1980 to 2013.

Authors:  Klaus Rostgaard; Henrik Hjalgrim; Laura Madanat-Harjuoja; Tom B Johannesen; Sofia Collin; Lisa L Hjalgrim
Journal:  Br J Cancer       Date:  2019-11-13       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.